IndiaTickerLatest filing: Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
ObservedCompany dossier
Alivus Life Sciences
NSE:ALIVUS · ISIN INE03Q201024
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Alivus Life Sciences
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹641.8 Cr · PAT ₹137 Cr.
Exchange XBRLLatest ownership: promoter group 74.87% and public 25.13% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
BSE · conference call
Observed
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Alivus Life Sciences Limited
NSE · conference call
Observed
Source filing Trading Window - Alivus Life Sciences Limited
NSE · exchange filing
Observed
Source filing Alivus Life Sciences Ltd - 543322 - Board Meeting Intimation for Considering And Approving Unaudited Financial Results Of The Company For The Quarter Ended 30Th June, 2026.
BSE · financial results
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹641.8 Cr
- Profit after tax
- ₹137 Cr
- EPS
- ₹11.18
Observed NSE structured filing · Non-Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 74.87%
- Public
- 25.13%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL